Vivaldi Biosciences Inc., a venture-backed company with operations at the Research Innovation Center at Colorado State University, has been issued a patent for its DeltaFLU universal influenza vaccine ...
With the arrival of winter, the Dominican Republic has seen a significant increase in respiratory viruses, especially influenza A and B, which cause the flu. Given this situation, the question arises: ...
We're almost in the peak of flu season, with the CDC's recent report saying activity is "low but rising." Here's what ...
A mutated strain of the flu is surging worldwide, sparking concerns about a severe flu season in the U.S. Here's what to ...
Flu season is underway across the U.S. — with particularly high activity across the state of Wisconsin. For the week ending Feb. 1, Wisconsin Department of Health Services data show influenza activity ...
The risk for medically attended influenza illness was lower among patients who received the influenza vaccine in the 2023 to 2024 season, with variations in protection observed across age groups and ...
An unexpected mutation of the H3N2 influenza A virus is driving up case counts abroad, and experts are concerned it could ...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended granting marketing authorization for Flucelvax Tetra (Seqirus Netherlands BV), a ...
Flu season typically runs from October to May, with the CDC recommending vaccination by the end of October. The 2025-2026 flu shot protects against three common influenza viruses and takes about two ...